Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

Share

Novo Nordisk Pharma Operations A/S

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 109,612 Less Arrow 108,302 More Arrow 211,440
Earnings before taxes 3,401 More Arrow 6,765 Less Arrow 4,779
Total assets 87,647 Less Arrow 77,875 More Arrow 135,750
Current assets 79,417 Less Arrow 69,808 Less Arrow 55,676
Current liabilities 43,045 Less Arrow 35,410 Less Arrow 34,957
Equity capital 31,223 Less Arrow 28,925 More Arrow 71,709
- share capital 500 Equal arrow 500 Equal arrow 500
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 35.6% More Arrow 37.1% More Arrow 52.8%
Turnover per employee
Profit as a percentage of turnover 3.1% More Arrow 6.2% Less Arrow 2.3%
Return on assets (ROA)
Current ratio 184.5% More Arrow 197.1% Less Arrow 159.3%
Return on equity (ROE) 10.9% More Arrow 23.4% Less Arrow 6.7%
Change turnover 1,310 Less Arrow -103,138 More Arrow 112,810
Change turnover % 1% Less Arrow -49% More Arrow 114%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.